Skip to main content
Premium Trial:

Request an Annual Quote

Schering Licenses Inpharmatica's Kinase SARfari Knowledge Base

NEW YORK (GenomeWeb News) — Inpharmatica today said that Schering AG has obtained a multi-year, multi-user license to its Kinase SARfari knowledge base.
The product covers the biology and chemistry of the major group of successful targets in drug discovery, and Schering will use it as part of its drug-discovery process in the field of protein kinases, Inpharmatica said.
Financial terms were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.